mustard
Commented by Matthias Schomber on June 26th, 2026 | 07:25 CEST
SAP Testing the Waters, BYD On the Offensive, and MustGrow Biologics Raises Fresh Capital - Is a Rebound on the Horizon?
Created and published on behalf of MustGrow Biologics Corp.
The winds across global equity markets have grown noticeably stronger, bringing sharp moves in both directions. Technology and automotive giants that have long been accustomed to success are feeling the full force of this turbulence. Faced with declining share prices and geopolitical uncertainty, investors are increasingly looking beyond the mainstream for fresh opportunities. While companies such as SAP and BYD are fighting to defend their lofty valuations, intriguing second-tier players are quietly positioning themselves for growth. This raises a legitimate question: should investors allocate capital into "fallen angels" such as SAP and BYD, or focus on lesser-known growth stories with potentially greater upside? We examine the current market environment and take a closer look at three very different companies. Discover why software heavyweight SAP and electric vehicle pioneer BYD are facing challenges, and why Canadian agtech company MustGrow Biologics could be approaching a breakout. One thing is certain: the stage is set for an exciting summer in the markets.
Read
Commented by Carsten Mainitz on June 25th, 2026 | 07:40 CEST
A Strong Duo in a Huge and Overlooked Growth Market: MustGrow Biologics and Bayer—When Will BayWa Recover?
Created and Published on Behalf of MustGrow Biologics Corp.
Global agriculture is undergoing a profound structural transformation. Climate change—marked by heat waves, droughts, and extreme weather events—is causing billions in crop losses annually in Europe alone. This is driving rising demand for more resilient farming systems and hardier crops. Regenerative agriculture and biological crop protection products are gaining strong momentum, forming the basis of emerging megatrends. According to expert estimates, the market for regenerative agriculture is expected to grow to around USD 50 billion by 2033. This is where the Canadian company MustGrow has positioned itself. Of particular importance is its licensing and development partnership with Bayer for biological crop protection solutions, which creates significant opportunities for this small-cap North American company.
Read
Commented by Nico Popp on June 19th, 2026 | 07:35 CEST
How MustGrow Biologics Benefits from Agrochemical Realignment with Patented Bioactive Technology – Pressure on Bayer and Corteva
Created and published on behalf of MustGrow Biologics Corp.
Extreme heat waves, increasingly degraded soils, and strict regulatory limits on synthetic chemical crop protection products—global agricultural markets are facing a critical period of adjustment. Once temperatures cross the critical threshold of 30 °C, most agricultural crops begin to suffer drastic yield losses, as sterile pollen and weakened cell walls cause irreparable damage to plant biology. According to the joint report by the Food and Agriculture Organization of the United Nations (FAO) and the World Meteorological Organization (WMO) titled "Extreme Heat and Agriculture," even individual heat waves can cause agricultural productivity to plummet by up to 50%. For most major crops, yield losses are already a threat at temperatures as low as 30 °C. The frequency, intensity, and duration of extreme heat events have increased significantly over the past 50 years. These ecological stressors are shifting growing conditions in both temperate and Mediterranean zones, forcing the entire agricultural value chain to rethink its approach.
Read
Commented by André Will-Laudien on June 16th, 2026 | 07:25 CEST
USA–Iran: The Strait of Hormuz is Opening Up! A Sector Buy Signal for Bayer, MustGrow, BASF and K+S!
Created and published on behalf of MustGrow Biologics Corp.
Some things are ultimately not surprising. The "agreement" between the USA–Israel and Iran resembles shadow boxing. One step forward, one step back—that is how the movements at the trading desk appear. The stock markets are reacting accordingly. At the start of the week, optimism about a near-term end to the hostilities is once again dominating. Oil prices are correcting most sharply, down nearly 5%, with Brent now quoted at only USD 82.50 per barrel. This is a positive signal for chemical- and transport-oriented industries in the food sector, with BASF and Bayer showing corresponding strength. Large volumes of goods must be transported globally, and shipping routes carry significant operational importance. As part of efforts to ensure long-term food security, more and more ideas are emerging that could mitigate the international energy crisis. MustGrow focuses on natural ingredients rather than chemicals, while K+S represents a typical example of the "old economy" in this sector. For investors, multiple opportunities for returns are available!
Read
Commented by Armin Schulz on June 11th, 2026 | 06:45 CEST
With Novo Nordisk, MustGrow Biologics, and Bayer: Positioning for Two Megatrends of the Decade
Created and published on behalf of MustGrow Biologics Corp.
Two seemingly opposing crises—obesity and food scarcity—are creating major investment opportunities this year. While the obesity epidemic is placing increasing strain on healthcare systems, climate shocks and geopolitical conflicts are threatening global agricultural yields. The biotech sector is addressing both challenges through biological compounds for weight management and crop protection. Demand for effective obesity treatments and sustainable agricultural solutions is rising rapidly. Investors who position themselves early in the beneficiaries of this dual transformation may benefit from above-average returns. This is precisely where the three companies we are taking a closer look at today are positioned: Novo Nordisk, MustGrow Biologics, and Bayer.
Read
Commented by Tarik Dede on June 9th, 2026 | 08:25 CEST
Agritech Stocks on the Rise: A Look at KWS Saat, MustGrow Biologics, and Bucher Industries!
Created and published on behalf of MustGrow Biologics Corp.
The world's population continues to grow, yet climate change, pesticides, and soil erosion are causing significant challenges to agricultural output. Without agritech companies, it would likely be impossible to feed the world today. At the same time, sustainable farming techniques and crop protection products are in demand; smart farming is a trend, and seeds are also crucial. That is why we are taking a look today at the shares of KWS Saat, MustGrow Biologics, and Bucher Industries.
Read
Commented by Matthias Schomber on June 5th, 2026 | 07:00 CEST
Global Food Security Meets Agritech Innovation: New Developments from Bayer, Nutrien, and MustGrow Biologics
Created and published on behalf of MustGrow Biologics Corp.
Global hunger has been rising dramatically for years and already affects over 750 million people worldwide. Geopolitical conflicts such as the war in Ukraine, the pandemic's aftermath, and intensifying droughts driven by the climate crisis are exposing the extreme vulnerability of our global food supply. To permanently reverse this dangerous trend, development organizations like Bread for the World are calling for a profound, ecological transformation away from pure agribusiness toward sustainable, resilient systems. In this context, agribusiness conglomerates and innovative pioneer companies are under significant pressure to deliver effective solutions quickly. But how are established industry leaders responding to these historic challenges, and what role do innovative organic approaches play in this future market worth hundreds of billions? A look at current market trends reveals where the momentum for a new era in agriculture is building.
Read
Commented by Jens Castner on June 3rd, 2026 | 07:10 CEST
HOT MUSTARD FOR SWEET FRUITS: HOW MUSTGROW BIOLOGICS IS SPARKING A REVOLUTION IN AGRICULTURE
Created and published on behalf of MustGrow Biologics Corp.
From summer strawberry stands to the stock market: as chemical pesticides and fertilizers face increasing regulatory pressure worldwide, demand for biological crop protection solutions is accelerating. Positioned at the forefront of this transition is MustGrow Biologics Corp. Leveraging the natural defence mechanisms of the mustard plant and supported by strategic industry partnerships, including Bayer, the company aims to scale its technology for global agricultural markets.
Read
Commented by André Will-Laudien on June 2nd, 2026 | 06:55 CEST
Stock Market Rotation Beyond AI: Opportunities in MustGrow, Bayer, and Novo Nordisk; Caution with K+S
Created and published on behalf of MustGrow Biologics Corp.
A shift in perspective remains the order of the day. Yesterday, the ECB met to discuss the current situation regarding inflation and interest rates. With an inflation rate of over 3% in Europe, there is likely no room for downward interest rate adjustments—quite the opposite! The 10-year yield on German government bonds has settled near the 3% mark over the past four weeks, while in the US, the 30-year yield is already above 5%. In the past, these were warning signs for a currently well-valued NASDAQ, as the so-called trailing P/E ratio has soared from 28 to 36. Growth companies, mostly financed through equity, thrive on tech euphoria, whereas capital-intensive industries, such as the life sciences sector, face a different situation. For example, Bayer and Novo Nordisk do not require market financing, as they hold large cash reserves. In the case of K+S, the ability to pass on prices to end customers could lead to rising cash flows, while the Canadian company MustGrow has only recently raised funds and is steadily continuing its rollout in the US. Mid-term investors should focus on sector rotation when tech momentum fades. The chances of a revival in neglected sectors look strong!
Read
Commented by Nico Popp on May 20th, 2026 | 08:30 CEST
Disruption in the Agricultural Sector: Why Corteva and Deere & Company Are Keeping an Eye on MustGrow Biologics
Created and published on behalf of MustGrow Biologics Corp.
High energy prices, soil degradation, and consumer preference for organic products—the growing pressure on traditional agricultural chemicals poses an existential challenge to established market leaders. Those who do not embrace biological alternatives now risk falling behind due to growing regulatory requirements and increasing resistance. Driven by historically high energy prices, which make the production of conventional fertilizers more expensive, agricultural businesses are facing cost pressures. This economic predicament is becoming a catalyst for innovation: major corporations are investing billions in digital solutions and biologically active ingredients. We shed light on this trend and introduce exciting companies.
Read